Labiotech.eu

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going in 2026? labiotech.eu/trends-news/bi…

Today we welcome Koenraad Wiedhaup, Co-Founder and CEO of Leyden Labs, and Clarissa Koch, the company's Chief Scientific Officer. labiotech.eu/podcast/how-le…

Various discoveries have driven neuroscience breakthroughs. For Brain Awareness Week, Labiotech spoke to experts in the field. labiotech.eu/in-depth/brain…

We look at six biotechs in Maryland that have received funding over the past five years that are ready to take their technologies further into the clinic. labiotech.eu/best-biotech/b…

We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in the coming years. labiotech.eu/in-depth/brist…

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease. labiotech.eu/best-biotech/p…

Delve into the complex field of colorectal cancer treatment, where it's increasingly about tailoring approaches to subgroups. labiotech.eu/in-depth/color…

Today, we welcome Janita Good, a Partner at Fieldfisher with nearly two decades of experience advising top organizations in pharmaceuticals, biotechnology, and medical devices. labiotech.eu/podcast/how-to…

After decades of research, the first ever cell rejuvenation therapy is about to hit the clinic. labiotech.eu/trends-news/ce…

Meet 5 hot biotechs in Arizona that have raised significant funding over the past decade as the state’s life sciences sector expands. labiotech.eu/best-biotech/b…

Learn about Carbios' story, as the French biotech focused on recycling polyethylene terephthalate (PET), faces pressure after its China deal. labiotech.eu/trends-news/ca…

Today we’re joined by Sean MacDonald, CEO of Kainova Therapeutics and we will dive into Kainova’s innovative GPCR-modulating platform. labiotech.eu/podcast/revers…

Biotech deals in February saw one of the biggest acquisitions in the biopharma space in recent times. labiotech.eu/trends-news/bi…

Delve into the field of pulmonary hypertension as GSK places a $950 million bet on a candidate following the footsteps of Winrevair. labiotech.eu/in-depth/hs235…

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development challenges. labiotech.eu/in-depth/rare-…

In this episode, Sergey Jakimov, the Founding and Managing Partner of LongeVC, warns about the rising danger of misinformation disguised as health advice. labiotech.eu/podcast/misinf…

New treatments for male infertility could widen therapeutic options and possibly shift the treatment burden from women. labiotech.eu/in-depth/new-m…

Delve into the biopharma giant Pfizer's strategy evolution into oncology and obesity beyond its success during the COVID pandemic. labiotech.eu/in-depth/pfize…

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root. labiotech.eu/best-biotech/r…

We take a look at Oxford’s biotech and life sciences hub to discover what makes this historical city a hotspot for scientific innovation. labiotech.eu/in-depth/oxfor…